Nike Inc

NKEStockConsumer Discretionary

Last analysed 7 Sep 2026 · Anchored at $38.42

8/ 10
AttractiveMedium

Nike at $38.42 is an attractive starter Buy, but the thesis depends on a partial earnings recovery rather than brand prestige alone.

Green team

The case for

Nike does not need heroic growth for the investment to work. The base case assumes only $50B of FY29 revenue and a 10.5% EBIT margin—both below FY24 levels—yet produces roughly $59 per share before dividends. Running has delivered five consecutive quarters of double-digit growth, wholesale is recovering, and North America is already showing revenue and EBIT improvement.

The balance sheet gives management time to execute without creditor pressure. If Running proves to be a template for broader product renewal and margins recover even partially, the current price offers substantial upside without requiring Nike to regain its former peak economics.

Red team

The case against

Nike is cheap on recovered earnings, not on current underlying cash generation. FY26 FCF was only about $2.18B, a 3.8% yield, dividends exceeded FCF, Nike Direct remains weak, and the turnaround has not yet proven itself beyond Running and North America.

China may be structurally impaired, while On, Hoka, Adidas and domestic Chinese competitors demonstrate that Nike's historic dominance has weakened. If category recovery fails to broaden and normalized revenue or margins are permanently lower, the apparent valuation discount can persist or deepen.

valu8 verdict

Nike at $38.42 is an attractive starter Buy, but the thesis depends on a partial earnings recovery rather than brand prestige alone. Running, wholesale and North America provide enough evidence that recovery is plausible, while the balance sheet gives management time to execute. A starter position is appropriate now, with further allocation dependent on broader margin, sell-through and category validation.

The debate

  • Is Nike's deterioration primarily a temporary strategic reset rather than permanent brand impairment?unresolved
  • Can the Running recovery spread into broader Sportswear and performance categories?unresolved
  • Are Nike's normalized China revenue and margins structurally lower than before?unresolved
  • Does Nike's balance sheet give management sufficient time to execute the turnaround?

Asymmetry

Failed recovery

Return %
-11.8%
Probability
30%
Condition
Structural brand erosion or a reset that largely fails, corresponding to the supplied $20 and $38 FY29 scenarios.

Base recovery

Return %
+66.3%
Probability
40%
Condition
Revenue reaches about $50B and EBIT margin recovers to 10.5%, still below FY24 levels.

Strong recovery

Return %
+137.5%
Probability
30%
Condition
Nike achieves the supplied strong-recovery or genuine-revival scenarios, with materially higher revenue and margins.

Green team was right

  • Running has produced five consecutive quarters of double-digit growth and gained share in key Western markets.
  • Wholesale and North America are already showing tangible improvement.
  • The balance sheet is strong enough to fund the turnaround without external capital.

Red team was right

  • Current cash earnings remain relatively expensive, with only a 3.8% trailing FCF yield.
  • China continues to deteriorate and may represent a structural rather than cyclical problem.
  • Competition is materially stronger and Nike's recovery remains unproven beyond Running and North America.

Deciding factor

The current price requires only a partial recovery in revenue and margins, while early evidence from Running and North America suggests that recovery is plausible.

What would change this

  • Running strength failing to spread into other categories would materially weaken the recovery thesis.
  • China declines beginning to narrow would improve confidence that structural impairment is limited.
  • Inventory units falling alongside improving full-price sell-through would support further allocation.
  • Sustained gross-margin improvement excluding tariff accounting would strengthen the normalized earnings case.

Key risk

Nike's normalized revenue and margins may be structurally lower because of lasting brand-share losses, particularly in China and against stronger competitors.

Not covered

The key evidence gap is whether Running's recovery translates into improving full-price sell-through and broader category and channel recovery.

Nike is cheap on recovered earnings, but the recovery still needs broader proof.

About Nike Inc

Under CEO Elliott Hill, Nike is rebuilding the operating model it drifted away from: sport-led product, athlete insight, and wholesale partners that can carry the line. Sport Offense is the name for that reset — smaller cross-functional teams around running, basketball, football and other core sports, faster innovation cycles, and less reliance on stretching classic franchises and promotions when newness ran thin.

The business still spans footwear, apparel and equipment under Nike, Jordan and Converse, through wholesale and Nike Direct across North America, Europe, Greater China and other markets. What changed is emphasis. After a stretch when lifestyle breadth and owned-channel growth got ahead of performance heat, Nike is trying to restore premium positioning through sport moments, clearer price architecture and marketplace elevation rather than pure Direct volume. Cost discipline and inventory cleanup sit alongside the product rethink.

Investors are watching NKE because early signals are uneven by design. Performance categories and wholesale can firm in some regions while Greater China and parts of the international footprint move on a longer clock, and while inventory, competition and a cooler consumer still weigh on the top line. Management has described progress as inconsistent and the turnaround as multi-year, with wins meant to scale from sport to sport and market to market.

The unresolved question is whether Sport Offense is deep enough to restore durable growth and brand heat — or whether Nike ends up with a healthier product engine that still cannot clear China, channel mix and competitive pressure on the timeline the market wants to see.